This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Lamant L, Espinos E, Duplantier M, Dastugne N, Robert A, Allouche M et al. Establishment of a novel anaplastic large cell lymphoma-cell line (COST) from a small cell variant of ALCL. Leukemia 2004, 18: 1693–1698.
Stein H, Mason DY, Gerdes J, O’Connor N, Wainscoat J, Pallesen G et al. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed–Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 1985; 66: 848–858.
Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML et al. Revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361–1392.
Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting – Airlie House, Virginia, November 1997. J Clin Oncol 1999; 17: 3835–3849.
Drexler HG, Gignac SM, von Wasielewski R, Werner M, Dirks WG . Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas. Leukemia 2000; 14: 1533–1559.
Stein H, Foss HD, Durkop H, Marafioti T, Delsol G, Pulford K et al. CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features. Blood 2000; 96: 3681–3695.
Falini B . Anaplastic large cell lymphoma: pathological, molecular and clinical features. Br J Haematol 2001; 114: 741–760.
Kadin ME, Morris SW . The t(2;5) in human lymphomas. Leukemia Lymphoma 1998; 29: 249–256.
Duyster J, Bai RY, Morris SW . Translocations involving anaplastic lymphoma kinase (ALK). Oncogene 2001; 20: 5623–5637.
Horie R, Watanabe M, Ishida T, Koiwa T, Aizawa S, Itoh K et al. The NPM-ALK oncoprotein abrogates CD30 signaling and constitutive NF-kappaB activation in anaplastic large cell lymphoma. Cancer Cell 2004; 5: 353–364.
Drexler HG, Matsuo Y, MacLeod RAF . Continuous hematopoietic cell lines as model systems for leukemia–lymphoma research. Leukemia Res 2000; 24: 881–911.
Nezelof C, Barbey S, Gogusev J, Terrier–Lacombe MJ . Malignant histiocytosis in childhood: a distinctive CD30-positive clinicopathological entity associated with a chromosomal translocation involving 5q35. Semin Diagn Pathol 1992; 9: 75–89.
Gogusev J, Nezelof C . Malignant histiocytosis. Histologic, cytochemical, chromosomal, and molecular data with a nosologic discussion. Hematol Oncol Clin North Am 1998; 12: 445–463.
Herbst H, Drexler HG . CD30-positive anaplastic large cell lymphoma cell lines. In: Masters JRW, Palsson BO (eds) Human Cell Culture, Vol. III – Cancer Cell Lines Part 3: Leukemias and Lymphomas. Dordrecht: Kluwer Academic Publishers, 2000, pp 355–370.
Drexler HG (ed). The Leukemia–Lymphoma Cell Line FactsBook. San Diego: Academic Press, 2000.
Dirks WG, Zaborski M, Jager K, Challier C, Shiota M, Quentmeier H et al. The (2;5)(p23;q35) translocation in cell lines derived from malignant lymphomas: absence of t(2;5) in Hodgkin-analogous cell lines. Leukemia 1996; 10: 142–149.
Shiota M, Fujimoto J, Semba T, Satoh H, Yamamoto T, Mori S . Hyperphosphorylation of a novel 80 kDa protein-tyrosine kinase similar to Ltk in a human Ki-1 lymphoma cell line, AMS3. Oncogene 1994; 9: 1567–1574.
Barbey S, Gogusev J, Mouly H, Le Pelletier O, Smith W, Richard S et al. DEL cell line: a ‘malignant histiocytosis’ CD30+ t(5;6)(q35;p21) cell line. Int J Cancer 1990; 45: 546–553.
Kubonishi I, Sonobe H, Miyagi T, Iwahara Y, Ohyashiki JH, Ohyashiki K et al. A Ki-1 (CD30)-positive T (E+, CD4+, Ia+)-cell line, DL-40, established from aggressive large cell lymphoma. Cancer Res 1990; 50: 7682–7685.
Del Mistro A, Leszl A, Bertorelle R, Calabro ML, Panozzo M, Menin C et al. A CD30-positive T cell line established from an aggressive anaplastic large cell lymphoma, originally diagnosed as Hodgkin's disease. Leukemia 1994; 8: 1214–1219.
Al-Hashmi I, Decoteau J, Gruss HJ, Zielenska M, Thorner P, Poon A et al. Establishment of a cytokine-producing anaplastic large-cell lymphoma cell line containing the t(2;5) translocation: potential role of cytokines in clinical manifestations. Leukemia Lymphoma 2001; 40: 599–611.
Su IJ, Balk SP, Kadin ME . Molecular basis for the aberrant expression of T cell antigens in postthymic T cell malignancies. Am J Pathol 1988; 132: 192–198.
Kadin ME, Cavaille-Col MW, Sioutos N, Fletcher JA, Morton CC, Pastuzak W et al. Childhood Ki-1+ anaplastic large cell lymphoma: establishment and characterization of a new tumor cell line transplantable to SCID mice. Blood 1990; 76: 354a.
Schiemann WP, Pfeifer WM, Levi E, Kadin ME, Lodish HF . A deletion in the gene for transforming growth factor beta type I receptor abolishes growth regulation by transforming growth factor beta in a cutaneous T-cell lymphoma. Blood 1999; 94: 2854–2861.
Fischer P, Nacheva E, Mason DY, Sherrington PD, Hoyle C, Hayhoe FG et al. A Ki-1 (CD30)-positive human cell line (Karpas 299) established from a high-grade non-Hodgkin's lymphoma, showing a 2;5 translocation and rearrangement of the T-cell receptor beta-chain gene. Blood 1988; 72: 234–240.
Shimakage M, Dezawa T, Tamura S, Tabata T, Aoyagi N, Koike M et al. A Ki-1-positive cell line expressing Epstein–Barr virus antigens, established from a child with Ki-1-positive lymphoma. Intervirology 1993; 36: 215–224.
Merz H, Lange K, Gaiser T, Muller A, Kapp U, Bittner C et al. Characterization of a novel human anaplastic large cell lymphoma cell line tumorigenic in SCID mice. Leukemia Lymphoma 2002; 43: 165–172.
Su IJ, Kadin ME . Expression of growth factor/receptor genes in postthymic T cell malignancies. Am J Pathol 1989; 135: 439–445.
Rimokh R, Magaud JP, Berger F, Samarut J, Coiffier B, Germain D et al. A translocation involving a specific breakpoint (q35) on chromosome 5 is characteristic of anaplastic large cell lymphoma (‘Ki-1 lymphoma’). Br J Haematol 1989; 71: 31–36.
Epstein AL, Kaplan HS . Biology of the human malignant lymphomas I Establishment in continuous cell culture and heterotransplantation of diffuse histiocytic lymphomas. Cancer 1974; 34: 1851–1872.
Morgan R, Smith SD, Hecht BK, Christy V, Mellentin JD, Warnke R et al. Lack of involvement of the c-fms and N-myc genes by chromosomal translocation t(2;5)(p23;q35) common to malignancies with features of so-called malignant histiocytosis. Blood 1989; 73: 2155–2164.
Morris SW, Kirstein MN, Valentine MB, Dittmer KG, Shapiro DN, Saltman DL et al. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science 1994; 263: 1281–1284.
Umiel T, Rettenmier CW, Siegel S, Ota S, Shimada H, Tran TW et al. Establishment and characterization of a human mixed-lineage, T-lymphoid/myeloid cell line (USP-91). Blood 1993; 82: 1829–1837.
Drexler HG, Dirks WG, Matsuo Y, MacLeod RAF . False leukemia-lymphoma cell lines: an update on over 500 cell lines. Leukemia 2003; 17: 416–426.
Al-Katib A, Abubakr Y, Mohamed A, Maki A, Diurec Z, Mohammad R . Multiple mechanisms of drug resistance in anaplastic large cell lymphoma. Blood 1994; 84: 638a.
MacLeod RAF, Drexler HG . Cytogenetic characterization of tumor cell lines. In: Langdon S (ed) Cancer Cell Culture – Methods and Protocols. Totowa, NJ: Humana Press, 2004, pp 57–76.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Drexler, H., MacLeod, R. Malignant hematopoietic cell lines: in vitro models for the study of anaplastic large-cell lymphoma. Leukemia 18, 1569–1571 (2004). https://doi.org/10.1038/sj.leu.2403465
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2403465